Brief: AFT Pharmaceuticals Sees FY25 Operating Profit Of NZ$22 Million To NZ$25 Million
22/05/2024 22:29
May 23 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ :
* FY 25 GUIDANCE FOR OPERATING PROFIT OF NZ$22 MILLION TO
NZ$25
MILLION
* FY DIVIDEND DECLARED OF 1.6 NZ CENTS PER SHARE
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV